Pablo Morgado-Cresta
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours.
Journal: ESMO real world data and digital oncology
Published: December 03, 2024
Harnessing Senolytics and PARP Inhibition to Expand the Antitumor Activity of CDK4/6 Inhibitors in Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: October 13, 2024
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis.
Journal: Cancer treatment reviews
Published: September 18, 2024
Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence.
Journal: Cell reports. Medicine
Published: July 21, 2024
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.
Journal: European urology
Published: December 20, 2023
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
Journal: NPJ precision oncology
Published: September 21, 2023
Comprehensive evaluation of surrogate endpoints to predict overall survival in trials with PD1/PD-L1 immune checkpoint inhibitors plus chemotherapy.
Journal: Cancer treatment reviews
Published: January 25, 2023
Clinical implications of homologous recombination repair mutations in prostate cancer.
Journal: The Prostate
Published: March 09, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026